Company Active PRIVATE-UNLIMITED

Company profile

Glaxosmithkline Services Unlimited

UK company 01047315, incorporated on 23 March 1972.

Patient Welcome Page

Glaxosmithkline Services Unlimited is a UK company with status active founded in 1972 based in London.

Company number
01047315
Incorporated
23 Mar 1972
Companies House status
Active

Company identity

Founded / incorporated
23 March 1972

Company number 01047315

Verify at Companies House
Legal name
GLAXOSMITHKLINE SERVICES UNLIMITED
Company type
PRIVATE-UNLIMITED
Region
London
Registered address
Unknown
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller
1
Company Active PRIVATE-UNLIMITED
Glaxosmithkline Services Unlimited
CRN 01047315
2
Direct and ultimate controller Active PLC
GSK PLC
CRN 03888792

Company events

Reference milestones and recent Companies House filing stream events.

2 events
10 Aug
2026

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzUzNzUxMjQzNmFkaXF6a2N4 | Paper/PDF filed

Published 11 Aug 2026 12:13

23 Mar
1972

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2013
Funded years
2013, 2014, 2025
Age at first award
41 years

Projects

2025 Feasibility Studies

Optimising Energy Efficiency for Sustainable Medicines Manufacturing

1 Jan 2025 to 31 May 2025

Awarded
£0
Total cost £18,164

This project introduces an innovative, large-scale approach to reducing energy consumption within the UK's medicines manufacturing sector, a sector that faces unique sustainability challenges due to its energy-intensive processes and stringent regulatory requirements. The project focuses on Productivity and Resource Efficiency, aiming to significantly low...

2014 Collaborative R&D

Accelerating paediatric formulation development through smart design and predictive science

1 Jul 2014 to 31 Mar 2018

Awarded
£70,959
Total cost £141,918

This project is a collaboration between large UK pharmaceutical companies, academia and technology suppliers to generate a structured approach to designing age-appropriate medicines for children and technology for predicting their quality and performance. Paediatric medicine is currently a "hot-topic" within the pharmaceutical industry and there is a lot ...

2014 Collaborative R&D

Digital Design of Drug Products

1 Jun 2014 to 31 May 2016

Awarded
£30,204
Total cost £60,408

This project brings together experts in drug development, product formulation, process design, systems modelling and manufacture to create a completely new approach to the design and manufacture of formulated drug products, which involves the integration of qualitative tools for process understanding with a range of in-silico models which describe and pre...

2013 Collaborative R&D

Development of an Innovative Modular System for Continuous Chemical Processing

1 Apr 2013 to 30 Sep 2016

Awarded
£10,000
Total cost £100,284

The project, lead by Syrris, in collaboration with GSK, AMRI UK and the EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation will develop an innovative modular system for continuous chemical processing. It will develop modules that can be used by any chemical industry to perform unit operations such as liquid-liquid, l...

Product types

Collaborative R&D Feasibility Studies